Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial
Open Access
- 16 October 2026
- journal article
- clinical trial
- Published by Georg Thieme Verlag KG in Endoscopy
Abstract
The association between serrated polyp detection rates, including proximal serrated polyp detection rate (PSPDR), and postcolonoscopy colorectal cancer (PCCRC) remains unestablished. We investigated PCCRC incidence and characteristics, and explored associations of PSPDR and adenoma detection rate (ADR) with PCCRC in colonoscopy- and fecal immunochemical test (FIT)-based screening within the Screening of Swedish Colons (SCREESCO) trial. Data from participants who underwent colonoscopy in the colonoscopy and FIT arms were analyzed. PCCRC, defined as colorectal cancer (CRC) diagnosed >6 months after a colonoscopy that did not detect CRC, was identified through linkage with cancer registries. Associations between PSPDR and PCCRC incidence were assessed using Cox models. Of 9982 and 5875 individuals in the colonoscopy and FIT arms, PCCRC was identified in 20 and 17 individuals, with 3-year PCCRC rates of 5.9% (3/51) and 3.5% (4/115), respectively. Compared with screening-detected CRC, PCCRC more often involved right-sided location and advanced stage. The 5-year cumulative incidence of PCCRC was 0.16% (95%CI 0.10%–0.27%) and 0.06% (95%CI 0.02%–0.15%) when colonoscopies were performed by endoscopists with low vs. high PSPDR (<10% vs. ≥10%), respectively. Among endoscopists with high ADR, 5-year PCCRC incidence was 0.13% (95%CI 0.04%–0.32%) vs. 0.06% (95%CI 0.02%–0.16%) for those with low vs. high PSPDR, respectively. Within this group, PCCRC incidence over 8 years decreased as PSPDR increased (hazard ratio per percentage-point increase, 0.90; 95%CI 0.82–1.00; P = 0.04). Despite the limited number of PCCRC events, this study suggests that PSPDR provides complementary information beyond ADR for identifying colonoscopies with higher PCCRC incidence.Keywords
Funding Information
- Regional Cancer Center Mellansverige
- 18 Swedish regions
- Swedish Cancer Society
- National Cancer Center Research and Development (2024-A-16)
- Aleris Research and Development Fund
- Eiken Chemical, Japan
- Stockholm County Council
This publication has 31 references indexed in Scilit:
- Sessile Serrated Lesion Detection Rate and Colorectal Cancer Risk and MortalityJAMA Network Open, 2026
- Rethinking Post-colonoscopy Colorectal Cancer Risk: Endoscopist Performance Versus Presence of High-risk PolypsClinical Gastroenterology and Hepatology, 2025
- Endoscopist adenoma detection rate associated with neoplasia detection during subsequent-round colonoscopy in fecal immunochemical test-based colorectal cancer screening: cross-sectional analysis of the SCREESCO randomized controlled trialGastrointestinal Endoscopy, 2025
- Systematic Review and Meta-analysis: The Three-year Post-colonoscopy Colorectal Cancer Rate as per the World Endoscopy Organization MethodologyClinical Gastroenterology and Hepatology, 2024
- Quality indicators for colonoscopyGastrointestinal Endoscopy, 2024
- Clinically significant serrated polyp detection rates and risk for postcolonoscopy colorectal cancer: data from the New Hampshire Colonoscopy RegistryGastrointestinal Endoscopy, 2022
- Postcolonoscopy Colorectal Cancer in Sweden From 2003 to 2012: Survival, Tumor Characteristics, and Risk FactorsClinical Gastroenterology and Hepatology, 2020
- Fecal Immunochemical Test Detects Sessile Serrated Adenomas and Polyps With a Low Level of SensitivityClinical Gastroenterology and Hepatology, 2017
- Endoscopic features of sessile serrated adenomas: validation by international experts using high-resolution white-light endoscopy and narrow-band imagingGastrointestinal Endoscopy, 2013
- The Swedish personal identity number: possibilities and pitfalls in healthcare and medical researchEuropean Journal of Epidemiology, 2009